FDA approved AstraZeneca’s Brilinta to reduce the risk of stroke
The FINANCIAL -- AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability ...
ADVERTISEMENT
Tag: risk of stroke
ADVERTISEMENT
Popular Last 24h
-
Jordan Fried’s Mission to Transform Puerto Rico Through Entrepreneurship
-
Kiel Institute Spring Forecast: Special Fund Would Give the Economy a Strong Boost
-
Ukraine Aid: Europe Could Replace most of US Support
-
The London Diplomatic List, Addresses, Contacts & Working Hours
-
How Can Chair Desk Combos Improve Student Focus and Classroom Efficiency?
-
Ampersand wins £22m five-year contract at London Zoo
-
Putin Rejects Ceasefire Proposal, Casting Doubt on Russia’s Intentions
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
